This MITACs proposal seeks funding to establish an internship cluster dedicated to researching novel psychedelic compounds for the purposes of treating clients suffering from PTSD and anxiety using its comprehensive psilocybin-assisted psychotherapy treatment model. The objective of this one-year project is to characterize the chemical composition of psychedelic mushrooms, optimizing extraction process, testing extracts and active compounds on insect model, in order to advance the science around the use of psilocybin in psychedelic-assisted psychotherapy.
Mental illness and addiction refer to a wide range of disorders that affects mood, behavior and thinking and thus leads to depression, anxiety disorders, substance use disorder and stress. The psychedelic drug assisted therapy functions as a mental health therapy, which is evolving at a quicker pace nowadays. These drugs are useful in the treatment of anxiety, depression, post-traumatic stress, obsessive-compulsive disorder, substance addiction, cancer-related and end of life anxieties.
Join a thriving innovation ecosystem. Subscribe now